Protara Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.7M | $172.6M | $35.7M |
| FY2022 | $11.2M | $113.3M | $24.1M |
| FY2023 | $10.6M | $79.0M | $39.6M |
| FY2024 | $14.3M | $181.5M | $162.8M |
| FY2025 | $13.1M | $209.5M | $49.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.7M | $172.6M | $35.7M |
| FY2022 | $11.2M | $113.3M | $24.1M |
| FY2023 | $10.6M | $79.0M | $39.6M |
| FY2024 | $14.3M | $181.5M | $162.8M |
| FY2025 | $13.1M | $209.5M | $49.7M |